TCG Crossover Management, LLC Diversified Active

Location: Palo Alto, CA

CIK: 0001839948 · Show all filings

Period: Q1 2024 (← Previous) (Next →)

Filing Date: May 15, 2024

Total Value: $1.265B (100.0% shares, 0.0% debt)

Holdings (33)

CGON CG ONCOLOGY, INC. 12.4%

Value $157M Shares 3,570,206 Est. Cost $40.84 Unrealized 0.0%

DYN DYNE THERAPEUTICS, INC 5.9%

Value $75.24M Shares 2,650,150 Est. Cost $16.62 Unrealized +36.1%

— ASTRIA THERAPEUTICS, INC. 5.9%

Value $74.3M Shares 5,278,928 Est. Cost $14.07 Unrealized —

SLN SILENCE THERAPEUTICS PLC 5.6%

Value $71.18M Shares 3,295,350 Est. Cost $14.21 Unrealized —

GPCR STRUCTURE THERAPEUTICS INC 5.4%

Value $68.51M Shares 1,598,421 Est. Cost $43.22 Unrealized —

— AEROVATE THERAPEUTICS INC 5.1%

Value $65.09M Shares 2,201,274 Est. Cost $15.75 Unrealized —

— INHIBRX,INC 4.8%

Value $61.19M Shares 1,750,387 Est. Cost $18.35 Unrealized —

KROS KEROS THERAPEUTICS, INC. 4.6%

Value $58.21M Shares 879,344 Est. Cost $59.30 Unrealized 0.0%

GERN GERON CORP 4.5%

Value $57.39M Shares 17,391,639 Est. Cost $1.89 Unrealized +18.4%

SVRA SAVARA INC. 3.9%

Value $49.8M Shares 10,000,000 Est. Cost $3.56 Unrealized +35.5%

OCUL OCULAR THERAPEUTIX, INC. 3.8%

Value $48.4M Shares 5,319,148 Est. Cost $7.10 Unrealized 0.0%

COGT COGENT BIOSCIENCES INC 3.3%

Value $41.76M Shares 6,214,375 Est. Cost $9.23 Unrealized -33.0%

EWTX EDGEWISE THERAPEUTICS, INC. 3.3%

Value $41.45M Shares 2,272,728 Est. Cost $15.89 Unrealized 0.0%

MLYS MINERALYS THERAPEUTICS, INC. 3.3%

Value $41.12M Shares 3,185,185 Est. Cost $12.35 Unrealized 0.0%

MDGL MADRIGAL PHARMACEUTICALS INC 3.2%

Value $39.86M Shares 149,283 Est. Cost $110.42 Unrealized +113.4%

— TOURMALINE BIO INC 2.7%

Value $33.84M Shares 1,477,593 Est. Cost $25.14 Unrealized —

TYRA TYRA BIOSCIENCES INC 2.6%

Value $32.62M Shares 1,989,103 Est. Cost $12.71 Unrealized +29.1%

CMPS COMPASS PATHWAYS PLC 2.5%

Value $32.1M Shares 3,858,000 Est. Cost $7.40 Unrealized —

KURA KURA ONCOLOGY INC 2.4%

Value $30.37M Shares 1,423,642 Est. Cost $14.54 Unrealized +33.7%

TARS TARSUS PHARMACEUTICALS, INC. 2.3%

Value $28.86M Shares 793,829 Est. Cost $17.70 Unrealized +66.2%

— ADVERUM BIOTECHNOLOGIES, INC. 2.2%

Value $28.4M Shares 2,008,340 Est. Cost $14.14 Unrealized —

— SOLENO THERAPEUTIVS, INC. 1.9%

Value $23.54M Shares 550,000 Est. Cost $42.80 Unrealized —

CNTA CENTESSA PHARMACEUTICALS PLC 1.8%

Value $23.06M Shares 2,040,816 Est. Cost $6.47 Unrealized —

ABVX Abivax SA 1.2%

Value $15.73M Shares 1,100,000 Est. Cost $10.70 Unrealized —

— VISTAGEN THERAPEUTICS INC 1.1%

Value $14.13M Shares 2,676,580 Est. Cost $5.14 Unrealized —

KALV KALVISTA PHARMACEUTICALS, INC 1.1%

Value $13.8M Shares 1,163,356 Est. Cost $5.36 Unrealized +148.9%

CCCC C4 THERAPEUTICS, INC. 0.8%

Value $10.43M Shares 1,276,574 Est. Cost $5.83 Unrealized +32.9%

TRDA ENTRADA THERAPEUTICS INC 0.7%

Value $8.289M Shares 584,955 Est. Cost $17.12 Unrealized —

ANTX AN2 Therapeutics, Inc. 0.4%

Value $5.054M Shares 1,555,118 Est. Cost $9.33 Unrealized +16.6%

KOD KODIAK SCIENCES INC 0.4%

Value $4.734M Shares 899,999 Est. Cost $4.10 Unrealized +19.4%

VTYX VENTYX BIOSCIENCES, INC 0.4%

Value $4.486M Shares 815,724 Est. Cost $29.94 Unrealized -84.7%

— NEKTAR THERAPEUTICS 0.3%

Value $3.737M Shares 4,000,000 Est. Cost $0.93 Unrealized —

CABA CABALETTA BIO, INC 0.1%

Value $1.481M Shares 86,795 Est. Cost $3.64 Unrealized +489.5%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
CGON	CG ONCOLOGY, INC.	3,570,206	$157M	12.4%	$40.84	0.0%	COMM	156944100
DYN	DYNE THERAPEUTICS, INC	2,650,150	$75.24M	5.9%	$16.62	+36.1%	COMM	26818M108
—	ASTRIA THERAPEUTICS, INC.	5,278,928	$74.3M	5.9%	$14.07	—	COMM	04635X102
SLN	SILENCE THERAPEUTICS PLC	3,295,350	$71.18M	5.6%	$14.21	—	ADRS	82686Q101
GPCR	STRUCTURE THERAPEUTICS INC	1,598,421	$68.51M	5.4%	$43.22	—	ADRS	86366E106
—	AEROVATE THERAPEUTICS INC	2,201,274	$65.09M	5.1%	$15.75	—	COMM	008064107
—	INHIBRX,INC	1,750,387	$61.19M	4.8%	$18.35	—	COMM	45720L107
KROS	KEROS THERAPEUTICS, INC.	879,344	$58.21M	4.6%	$59.30	0.0%	COMM	492327101
GERN	GERON CORP	17,391,639	$57.39M	4.5%	$1.89	+18.4%	COMM	374163103
SVRA	SAVARA INC.	10,000,000	$49.8M	3.9%	$3.56	+35.5%	COMM	805111101
OCUL	OCULAR THERAPEUTIX, INC.	5,319,148	$48.4M	3.8%	$7.10	0.0%	COMM	67576A100
COGT	COGENT BIOSCIENCES INC	6,214,375	$41.76M	3.3%	$9.23	-33.0%	COMM	19240Q201
EWTX	EDGEWISE THERAPEUTICS, INC.	2,272,728	$41.45M	3.3%	$15.89	0.0%	COMM	28036F105
MLYS	MINERALYS THERAPEUTICS, INC.	3,185,185	$41.12M	3.3%	$12.35	0.0%	COMM	603170101
MDGL	MADRIGAL PHARMACEUTICALS INC	149,283	$39.86M	3.2%	$110.42	+113.4%	COMM	558868105
—	TOURMALINE BIO INC	1,477,593	$33.84M	2.7%	$25.14	—	COMM	89157D105
TYRA	TYRA BIOSCIENCES INC	1,989,103	$32.62M	2.6%	$12.71	+29.1%	COMM	90240B106
CMPS	COMPASS PATHWAYS PLC	3,858,000	$32.1M	2.5%	$7.40	—	ADRS	20451W101
KURA	KURA ONCOLOGY INC	1,423,642	$30.37M	2.4%	$14.54	+33.7%	COMM	50127T109
TARS	TARSUS PHARMACEUTICALS, INC.	793,829	$28.86M	2.3%	$17.70	+66.2%	COMM	87650L103
—	ADVERUM BIOTECHNOLOGIES, INC.	2,008,340	$28.4M	2.2%	$14.14	—	COMM	00773U108
—	SOLENO THERAPEUTIVS, INC.	550,000	$23.54M	1.9%	$42.80	—	COMM	834203200
CNTA	CENTESSA PHARMACEUTICALS PLC	2,040,816	$23.06M	1.8%	$6.47	—	COMM	152309100
ABVX	Abivax SA	1,100,000	$15.73M	1.2%	$10.70	—	ADRS	00370M103
—	VISTAGEN THERAPEUTICS INC	2,676,580	$14.13M	1.1%	$5.14	—	COMM	92840H202
KALV	KALVISTA PHARMACEUTICALS, INC	1,163,356	$13.8M	1.1%	$5.36	+148.9%	COMM	483497103
CCCC	C4 THERAPEUTICS, INC.	1,276,574	$10.43M	0.8%	$5.83	+32.9%	COMM	12529R107
TRDA	ENTRADA THERAPEUTICS INC	584,955	$8.289M	0.7%	$17.12	—	COMM	29384C108
ANTX	AN2 Therapeutics, Inc.	1,555,118	$5.054M	0.4%	$9.33	+16.6%	COMM	037326105
KOD	KODIAK SCIENCES INC	899,999	$4.734M	0.4%	$4.10	+19.4%	COMM	50015M109
VTYX	VENTYX BIOSCIENCES, INC	815,724	$4.486M	0.4%	$29.94	-84.7%	COMM	92332V107
—	NEKTAR THERAPEUTICS	4,000,000	$3.737M	0.3%	$0.93	—	COMM	640268108
CABA	CABALETTA BIO, INC	86,795	$1.481M	0.1%	$3.64	+489.5%	COMM	12674W109